Timeline: the Lipitor patent row
By Hannah Flynn
The drug Lipitor is currently the focus of a patent row following the launch of a generic version of atorvastatin by Teva UK. Patent-holder Pfizer has obtained an injunctiion against the sale and distribution of the product, but the legal case continues. See C+D's timeline to see how events unfolded.



